The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

被引:0
作者
Avramenko, N. V. [1 ,2 ]
Kabachenko, O. V. [2 ]
Barkovskyi, D. Ye. [2 ]
Sierykh, K. V. [2 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Zaporizhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Dept Obstet Gynecol & Reprod Med, Zaporizhia, Ukraine
关键词
obesity; metabolic syndrome; polycystic ovary syndrome; adolescence; diagnosis; treatment; prevention; ASSOCIATIONS; MANAGEMENT; OBESITY; HEALTH; RISK;
D O I
10.14739/2310-1210.2023.3.251479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary -de-pendent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome ty-pical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 50 条
  • [1] Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome
    da Silva Bouzas, Isabel Cristina
    Cader, Samaria Ali
    Leao, Lenora
    Kuschnir, Maria Cristina
    Braga, Claudia
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2014, 27 (06) : 335 - 341
  • [2] Treatment of Polycystic Ovary Syndrome in Adolescence
    Vitek, Wendy
    Hoeger, Kathleen M.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (03) : 214 - 221
  • [3] Metabolic syndrome in adolescents with polycystic ovary syndrome
    Vrbikova, Jana
    Zamrazilova, Hana
    Sedlackova, Barbora
    Sanajderova, Marta
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (10) : 820 - 822
  • [4] Metabolic syndrome and polycystic ovary syndrome
    Sobstyl, Malgorzata
    Tkaczuk-Wlach, Joanna
    Sobstyl, Jacek
    Jakiel, Grzegorz
    PRZEGLAD MENOPAUZALNY, 2011, 10 (01): : 74 - 78
  • [5] Polycystic ovary syndrome update in adolescence
    Hassan, Areej
    Gordon, Catherine M.
    CURRENT OPINION IN PEDIATRICS, 2007, 19 (04) : 389 - 397
  • [6] The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome
    de Medeiros, Sebastiao Freitas
    de Medeiros, Matheus Antonio Souto
    Barbosa, Bruna Barcelo
    Yamamoto, Marcia Marly Winck
    METABOLIC SYNDROME AND RELATED DISORDERS, 2021, 19 (01) : 18 - 25
  • [7] Metabolic syndrome in patients with the polycystic ovary syndrome
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 559 - 568
  • [8] Polycystic Ovary Syndrome in Adolescence
    Joham, Anju E.
    Pena, Alexia S.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2022, 40 (01/02) : E1 - E8
  • [9] Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management
    Manique, Mariana Enxuto Santos
    Ferreira, Ana Margarida Antunes Povoa
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2022, 44 (04): : 425 - 433
  • [10] Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome
    Ulrich, Jan
    Goerges, Julia
    Keck, Christoph
    Mueller-Wieland, Dirk
    Diederich, Sven
    Janssen, Onno Eilard
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2018, 126 (04) : 198 - 204